Lipodystrophy for the Diabetologist-What to Look For.


Journal

Current diabetes reports
ISSN: 1539-0829
Titre abrégé: Curr Diab Rep
Pays: United States
ID NLM: 101093791

Informations de publication

Date de publication:
09 2022
Historique:
accepted: 03 06 2022
pubmed: 14 7 2022
medline: 10 8 2022
entrez: 13 7 2022
Statut: ppublish

Résumé

Genetic or acquired lipodystrophies are characterized by selective loss of body fat along with predisposition towards metabolic complications of insulin resistance, such as diabetes mellitus, hypertriglyceridemia, hepatic steatosis, polycystic ovarian syndrome, and acanthosis nigricans. In this review, we discuss the various subtypes and when to suspect and how to diagnose lipodystrophy. The four major subtypes are autosomal recessive, congenital generalized lipodystrophy (CGL); acquired generalized lipodystrophy (AGL), mostly an autoimmune disorder; autosomal dominant or recessive familial partial lipodystrophy (FPLD); and acquired partial lipodystrophy (APL), an autoimmune disorder. Diagnosis of lipodystrophy is mainly based upon physical examination findings of loss of body fat and can be supported by body composition analysis by skinfold measurements, dual-energy x-ray absorptiometry, and whole-body magnetic resonance imaging. Confirmatory genetic testing is helpful in the proband and at-risk family members with suspected genetic lipodystrophies. The treatment is directed towards the specific comorbidities and metabolic complications, and there is no treatment to reverse body fat loss. Metreleptin should be considered as the first-line therapy for metabolic complications in patients with generalized lipodystrophy and for prevention of comorbidities in children. Metformin and insulin therapy are the best options for treating hyperglycemia and fibrates and/or fish oil for hypertriglyceridemia. Lipodystrophy should be suspected in lean and muscular subjects presenting with diabetes mellitus, hypertriglyceridemia, non-alcoholic fatty liver disease, polycystic ovarian syndrome, or amenorrhea. Diabetologists should be aware of lipodystrophies and consider genetic varieties as an important subtype of monogenic diabetes.

Identifiants

pubmed: 35821558
doi: 10.1007/s11892-022-01485-w
pii: 10.1007/s11892-022-01485-w
pmc: PMC10704567
mid: NIHMS1850376
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-470

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK105448
Pays : United States

Informations de copyright

© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

EMBO Mol Med. 2009 Aug;1(5):280-7
pubmed: 20049731
Nat Genet. 2002 May;31(1):21-3
pubmed: 11967537
Nature. 2003 May 15;423(6937):293-8
pubmed: 12714972
J Clin Endocrinol Metab. 2012 Mar;97(3):785-92
pubmed: 22170723
J Clin Endocrinol Metab. 1992 Aug;75(2):358-61
pubmed: 1639935
J Clin Endocrinol Metab. 2002 May;87(5):2395
pubmed: 11994394
J Clin Endocrinol Metab. 2000 May;85(5):1776-82
pubmed: 10843151
N Engl J Med. 2002 Feb 21;346(8):570-8
pubmed: 11856796
N Engl J Med. 2004 Mar 18;350(12):1220-34
pubmed: 15028826
J Clin Endocrinol Metab. 2008 Apr;93(4):1129-34
pubmed: 18211975
Acta Paediatr Suppl. 1996 Jun;413:44-51
pubmed: 8783772
Ann Intern Med. 1968 Sep;69(3):501-16
pubmed: 5673170
J Clin Endocrinol Metab. 2003 Oct;88(10):4840-7
pubmed: 14557463
J Gastrointest Surg. 2017 Apr;21(4):739-743
pubmed: 27778252
Am Heart J. 2015 Apr;169(4):587-93
pubmed: 25819867
Nat Genet. 2001 Aug;28(4):365-70
pubmed: 11479539
J Clin Endocrinol Metab. 2004 Jul;89(7):3199-207
pubmed: 15240593
Diabetes Metab Syndr Obes. 2017 Sep 13;10:375-383
pubmed: 29066925
Clin Endocrinol (Oxf). 2011 Sep;75(3):403-4
pubmed: 21521325
Diabetes Obes Metab. 2008 Dec;10(12):1275-6
pubmed: 19040647
J Endocr Soc. 2019 Jun 24;3(9):1663-1677
pubmed: 31428720
Med Sci Sports Exerc. 1980;12(3):175-81
pubmed: 7402053
Clin J Am Soc Nephrol. 2006 Jul;1(4):616-22
pubmed: 17699267
Front Immunol. 2018 Sep 19;9:2142
pubmed: 30283460
Eur J Med Genet. 2014 Sep;57(9):524-6
pubmed: 24980513
Diabetes. 2015 Jan;64(1):299-310
pubmed: 25114292
J Clin Endocrinol Metab. 2015 May;100(5):1802-10
pubmed: 25734254
Lipids Health Dis. 2008 Jan 31;7:3
pubmed: 18237401
Can J Cardiol. 2014 Dec;30(12):1649-54
pubmed: 25475467
Obes Surg. 2006 Nov;16(11):1542-4
pubmed: 17132423
Medicine (Baltimore). 2004 Jan;83(1):18-34
pubmed: 14747765
Br J Nutr. 1978 Nov;40(3):497-504
pubmed: 718832
J Clin Endocrinol Metab. 1998 Feb;83(2):503-8
pubmed: 9467565
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7054-9
pubmed: 24778225
N Engl J Med. 2011 Feb 24;364(8):740-8
pubmed: 21345103
Nat Rev Endocrinol. 2015 Sep;11(9):522-34
pubmed: 26239609
Int J Obes Relat Metab Disord. 1999 Mar;23(3):253-9
pubmed: 10193870
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8901-6
pubmed: 24889630
J Hum Genet. 2014 Jan;59(1):16-23
pubmed: 24152769
Obstet Gynecol. 2012 Feb;119(2 Pt 2):452-455
pubmed: 22270436
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32193531
Diabetes Care. 2003 May;26(5):1350-5
pubmed: 12716787
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511
pubmed: 27710244
Eur J Endocrinol. 2022 Jan 28;186(3):C1-C4
pubmed: 34935636
Diabetes. 2020 Feb;69(2):249-258
pubmed: 31836692
Pathology. 2019 Feb;51(2):202-212
pubmed: 30595509
Q J Med. 1974 Jan;43(169):33-48
pubmed: 4362786
Nat Genet. 2000 Feb;24(2):153-6
pubmed: 10655060
Diabetes Care. 2006 Jun;29(6):1380-2
pubmed: 16732025
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1099-1108
pubmed: 30418556
Circulation. 2001 May 8;103(18):2225-9
pubmed: 11342468
Orphanet J Rare Dis. 2013 Jul 12;8:106
pubmed: 23849162
Br J Dermatol. 2020 Feb;182(2):477-480
pubmed: 31077337
N Engl J Med. 1975 Jan 2;292(1):35-41
pubmed: 1088918
Nat Genet. 2014 Nov;46(11):1239-44
pubmed: 25261934
J Clin Endocrinol Metab. 2002 Jan;87(1):408-11
pubmed: 11788685
J Med Case Rep. 2017 Jan 13;11(1):12
pubmed: 28086952
J Clin Endocrinol Metab. 2009 Jan;94(1):10-6
pubmed: 18854390
J Clin Endocrinol Metab. 2008 Jan;93(1):26-31
pubmed: 17940115
Acta Paediatr Suppl. 1996 Jun;413:2-28
pubmed: 8783769
Hum Mol Genet. 2003 Aug 15;12(16):1995-2001
pubmed: 12913070
Clin Endocrinol (Oxf). 2018 Jul;89(1):65-75
pubmed: 29722904
J Pediatr Endocrinol Metab. 2012;25(11-12):1157-60
pubmed: 23444474
J Clin Endocrinol Metab. 2010 Mar;95(3):1463-8
pubmed: 20097706
Hum Mol Genet. 2000 Jan 1;9(1):109-12
pubmed: 10587585
Science. 2004 May 28;304(5675):1325-8
pubmed: 15166380
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3616-3620
pubmed: 28973478
Am J Med. 2000 Feb;108(2):143-52
pubmed: 11126308
Am J Hum Genet. 2010 Dec 10;87(6):866-72
pubmed: 21129723
J Med Genet. 2002 Oct;39(10):722-33
pubmed: 12362029
Am J Med Genet A. 2011 Nov;155A(11):2617-25
pubmed: 21932319
Horm Metab Res. 2012 Apr;44(4):306-11
pubmed: 22274718
Hum Mol Genet. 2015 Aug 1;24(15):4238-49
pubmed: 25934999
BMJ Case Rep. 2018 Aug 3;2018:
pubmed: 30076164
J Clin Endocrinol Metab. 2011 Nov;96(11):3313-25
pubmed: 21865368
J Clin Endocrinol Metab. 2015 Oct;100(10):3603-6
pubmed: 26252356
Endocr Pract. 2013 Jan-Feb;19(1):107-16
pubmed: 23435042
J Clin Endocrinol Metab. 1999 Jan;84(1):170-4
pubmed: 9920078
N Engl J Med. 2014 Jun 12;370(24):2307-2315
pubmed: 24848981
Diabet Med. 2017 Dec;34(12):1792-1794
pubmed: 29044799
Diabetes Care. 2019 Oct;42(10):2008-2010
pubmed: 31434650
Eur J Endocrinol. 2021 Nov 10;185(6):841-854
pubmed: 34643546
Medicine (Baltimore). 2003 Mar;82(2):129-46
pubmed: 12640189
Nat Genet. 2013 Aug;45(8):947-50
pubmed: 23770608
Skeletal Radiol. 1992;21(6):381-6
pubmed: 1523434
PLoS Med. 2018 Sep 21;15(9):e1002654
pubmed: 30240442
Science. 2003 Jun 27;300(5628):2055
pubmed: 12702809
Diabetes. 2023 Jan 1;72(1):59-70
pubmed: 35709010
J Clin Invest. 2009 Sep;119(9):2623-33
pubmed: 19726876
Am J Hum Genet. 2002 Aug;71(2):426-31
pubmed: 12075506
Am J Hum Genet. 2013 Jul 11;93(1):141-9
pubmed: 23810378
Am J Hum Genet. 2015 Feb 5;96(2):295-300
pubmed: 25620207
Diabetes Care. 2003 Jun;26(6):1819-24
pubmed: 12766116
Pediatrics. 2007 Aug;120(2):e291-6
pubmed: 17671040
Am J Med Genet A. 2015 Aug;167A(8):1796-806
pubmed: 25898808
J Clin Endocrinol Metab. 1995 Oct;80(10):3077-81
pubmed: 7559900
Am J Med Genet A. 2010 Nov;152A(11):2749-55
pubmed: 20979188

Auteurs

Nivedita Patni (N)

Division of Pediatric Endocrinology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA.

Abhimanyu Garg (A)

Division of Nutrition and Metabolic Diseases, Department of Internal Medicine and the Center for Human Nutrition, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-8537, USA. abhimanyu.garg@utsouthwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH